Difference between revisions of "Kuba K, et al, Nat Med (2005), cited as Ref 10 in DOI: 10.1007/s11886-020-01293-2 (Q11004)"
Jump to navigation
Jump to search
(Created claim: Published In Name String (P102): Nat Med, #quickstatements; #temporary_batch_1592836225919) |
(Created claim: DOI Identifier (P138): 10.1038/nm1267, #quickstatements; #temporary_batch_1592836326594) |
||
| Property / DOI Identifier | |||
| + | |||
| Property / DOI Identifier: 10.1038/nm1267 / rank | |||
| + | Normal rank | ||
Revision as of 14:32, 22 June 2020
Cited in: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty" Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Kuba K, et al, Nat Med (2005), cited as Ref 10 in DOI: 10.1007/s11886-020-01293-2
|
Cited in: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty" Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34.
|
Statements
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury (English)
0 references
2005
0 references
Kuba K
0 references
Imai Y
0 references
Rao S
0 references
Gao H
0 references
Guo F
0 references
Guan B
0 references
Huan Y
0 references
Yang P
0 references
Zhang Y
0 references
Deng W
0 references
Nat Med
0 references
